Subscribe to stay informed!
Exton-based Immunome has entered into a deal with a group of accredited investors to raise $27 million through a private stock placement, writes John…
Sanofi U.S., a division of the French pharmaceutical company Sanofi, is planning to close its Great Valley plant in Malvern. If it’s shuttered…
Malvern-based Ocugen collaborated with India’s Bharat Biotech to develop a fourth vaccine, and it could be a game-changer in the ongoing fight…
Business is booming for Exton-based West Pharmaceutical Services, the world’s leading manufacturer of rubber stoppers. The circular plugs seal vials of vaccines and…
West Chester-based Verrica Pharmaceuticals is looking to raise around $30 million from its public stock offering, writes John George for The Philadelphia Business Journal…
Malvern-based XyloCor Therapeutics has closed a $41.9 million venture capital funding round, writes John George for the Philadelphia Business Journal.
The gene therapy…
After pushing the launch of its new cellulite treatment, Qwo, to this spring due to the pandemic, Malvern-based Endo International has been building momentum…
Immunome saw its stock soar after the Exton-based company discovered antibodies that have shown, in early testing, the ability to neutralize multiple variants of…
AmerisourceBergen is preparing to move from Chesterbrook to its new headquarters in Conshohocken this summer when the office component of the Sora West mixed-use…
After wrapping up his seven-month role in public service as a top scientist at Operation Warp Speed – the effort by former President Donald Trump…
After failing to develop a COVID-19 vaccine despite being considered a frontrunner in the race, Merck, which has a significant presence in Montgomery County…
Malvern-based Ocugen’s stock increased nearly 201 percent after announcing its plans for a direct stock offering worth $23 million, writes John George for…
Chris Visco, the co-founder and CEO of Jenkintown-based TerraVida Holistic Centers, which has a location in Malvern, is striking out on her own…
Malvern-based Ocugen has finalized a deal with Bharat Biotech to develop the India-based company’s COVID-19 vaccine, Covaxin, for the U.S…
Neuronetics, a Malvern-based medical device developer, is expecting to raise $75 million from its public stock offering, writes John George for the Philadelphia Business…
Before we send you to this site, please subscribe to our daily newsletter.